Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease-Reference-Cited by-同舟云学术

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

Published:2013-03-14 Issue:1 Volume:10 Page:53-61
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Rembach Alan¹,Faux Noel G.¹,Watt Andrew D.¹,Pertile Kelly K.¹,Rumble Rebecca L.¹,Trounson Brett O.¹,Fowler Christopher J.¹,Roberts Blaine R.¹,Perez Keyla A.¹,Li Qiao‐Xin¹,Laws Simon M.²³,Taddei Kevin²³,Rainey‐Smith Stephanie²³,Robertson Joanne S.¹,Vandijck Manu⁴,Vanderstichele Hugo⁴⁵,Barnham Kevin J.¹,Ellis Kathryn A.¹⁶⁷,Szoeke Cassandra⁶⁷,Macaulay Lance⁸,Rowe Christopher C.⁹,Villemagne Victor L.¹⁹,Ames David⁷,Martins Ralph N.²³,Bush Ashley I.¹,Masters Colin L.¹,

Affiliation:

1. The Mental Health Research InstituteThe University of MelbourneVictoriaAustralia

2. Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital)PerthWestern AustraliaAustralia

3. Centre of Excellence for Alzheimer's Disease Research & CareSchool of Medical Sciences, Edith Cowan UniversityJoondalupWestern AustraliaAustralia

4. Department of Diagnostic DevelopmentInnogenetics NVGhentBelgium

5. BiomarkableGentBelgium

6. Department of PsychiatrySt George's Hospital, University of MelbourneVictoriaAustralia

7. National Ageing Research InstituteParkvilleVictoriaAustralia

8. CSIRO Molecular and Health TechnologiesParkvilleVictoriaAustralia

9. Department of Nuclear Medicine and Centre for PETAustin HealthHeidelbergVictoriaAustralia

Funder

Commonwealth Scientific and Industrial Research Organisation

National Health and Medical Research Council

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2012.12.006

Reference28 articles.

1. Resolving controversies on the path to Alzheimer's therapeutics

2. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

4. Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease

5. Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer’s disease progression;Nature Communications;2024-09-12

2. A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer’s disease (ART-AD);2024-02-28

3. Comparing Symmetric Dimethylarginine and Amyloid-β42 as Predictors of Alzheimer’s Disease Development;Journal of Alzheimer's Disease Reports;2023-12-29

4. Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers;International Journal of Molecular Sciences;2023-09-15

5. The Role of Binding Site Specificity in the Disaggregation of Aβ₄₂Fibrils through a Synthetic Paratope;2023-08-14